Loading clinical trials...
Loading clinical trials...
Aim is to to demonstrate that the ResAppDx v2.0 algorithms provide an accurate diagnosis of respiratory disease in the study's clinical setting compared to a clinical adjudication committee's (CAC) di...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
ResApp Health Limited
NCT07486401 · Asthma Exacerbations, Biomarkers / Blood, and more
NCT05825014 · COPD Exacerbation
NCT07351929 · COPD Exacerbation
NCT07261423 · Childhood Asthma, Asthma Control, and more
NCT07052942 · Asthma, Asthma Attack, and more
Addenbrookes Hospital
London
The Royal London Hospital
London
University College London Hospital
London
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions